These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y Respiration; 2013; 85(6):456-63. PubMed ID: 23257350 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation. Cottini SR; Brandi G; Pagnamenta A; Weder W; Schuepbach RA; Béchir M; Huber LC; Benden C Clin Transplant; 2018 May; 32(5):e13251. PubMed ID: 29707826 [TBL] [Abstract][Full Text] [Related]
19. [Risk factors of early death after lung transplantation in patients with idiopathic pulmonary fibrosis complicated with pulmonary arterial hypertension]. Hu C; Liu M; Yu H; Wang J; Li X; Yue B; Huang D; Hu C; Chen J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Feb; 35(2):124-129. PubMed ID: 36916370 [TBL] [Abstract][Full Text] [Related]
20. Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis. Moneke I; Ogutur ED; Kornyeva A; Fähndrich S; Schibilsky D; Bierbaum S; Czerny M; Stolz D; Passlick B; Jungraithmayr W; Frye BC BMC Pulm Med; 2024 Oct; 24(1):499. PubMed ID: 39385110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]